<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Cardiothorac Surg</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Cardiothorac Surg</journal-id>
      <journal-title-group>
        <journal-title>Journal of Cardiothoracic Surgery</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1749-8090</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27503339</article-id>
      <article-id pub-id-type="pmc">4977695</article-id>
      <article-id pub-id-type="publisher-id">521</article-id>
      <article-id pub-id-type="doi">10.1186/s13019-016-0521-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Transapical aortic valve implantation in patients with pre-existing mitral valve prostheses: a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Wachter</surname>
            <given-names>Kristina</given-names>
          </name>
          <address>
            <phone>+49-711-8101-3650</phone>
            <email>kristina.wachter@rbk.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ahad</surname>
            <given-names>Samir</given-names>
          </name>
          <address>
            <email>samir.ahad@rbk.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rustenbach</surname>
            <given-names>Christian J.</given-names>
          </name>
          <address>
            <email>christian.rustenbach@rbk.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Franke</surname>
            <given-names>Ulrich F. W.</given-names>
          </name>
          <address>
            <email>ulrich.franke@rbk.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baumbach</surname>
            <given-names>Hardy</given-names>
          </name>
          <address>
            <email>hardy.baumbach@rbk.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Department of Cardiovascular Surgery, Robert-Bosch-Hospital, Auerbachstr. 110, D-70376 Stuttgart, Germany </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>8</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>11</volume>
      <elocation-id>133</elocation-id>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>5</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>7</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s). 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Transcatheter aortic valve implantation (TAVI) has proven to be a valid option for patients with severe aortic stenosis who are at high perioperative risk, particularly in patients with previous cardiac surgery. Several patients with previous mitral valve surgery were reported to have been successfully treated with TAVI.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>Two patients, one with mechanical and one with biological mitral valve prosthesis, presented with symptomatic severe aortic stenosis. After discussion among our multidisciplinary heart team transapical approach and a JenaValve&#x2122; prosthesis was used for TAVI. Main reasons were to decrease the perioperative risk, avoid a re-opening of the chest via median sternotomy, and discuss the possible superiority of the JenaValve&#x2122; device due to its design. The patients were successfully treated and discharged on the 11th and 14th post-operative day, respectively. Echocardiographic follow up before discharge and up to 2.8&#xA0;years post-operatively showed excellent results.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>In conclusion, TAVI in patients with preexisting mitral prostheses-mechanical or biological-is feasible, safe, and effective and offers a valid alternative to conventional aortic valve replacement in this particular re-operation scenario. The JenaValve&#x2122; device does not interact with the mitral prosthesis and offers therefore due to its unique design a potential advantage.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Heart valve prosthesis</kwd>
        <kwd>Transcatheter aortic valve replacement</kwd>
        <kwd>Mitral valve</kwd>
        <kwd>Minimally invasive surgical procedures</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Considerable proportion of patients who require mitral valve replacement (MVR) presents with a coexisting pathology of the aortic valve [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>] with a possible necessity of surgery of the aortic valve in the following years. On the other hand, the perioperative risk of morbidity and mortality is elevated in patients undergoing conventional aortic valve replacement with previous median sternotomy [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
      <p>Transcatheter aortic valve implantation (TAVI) is nowadays an approved treatment for aortic stenosis (AS) in patients who are at high surgical risk [<xref ref-type="bibr" rid="CR4">4</xref>] and it can further reduce perioperative risk especially in patients who had undergone previous cardiac surgery as there is potentially less surgical trauma [<xref ref-type="bibr" rid="CR5">5</xref>]. Nevertheless, previous coronary artery bypass grafting (CABG), aortic valve replacement (AVR) or mitral valve replacement pose unknown risks when TAVI is performed.</p>
      <p>We report two cases of severe AS treated by transapical TAVI in patients who underwent previously MVR with a mechanical and biological valve, respectively.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>The first case is a 76&#xA0;year old patient presented to our hospital with progressive dyspnea, currently NYHA class III (New York Heart Association) and recurrent cardiac decompensation with a right pleural effusion and consecutive dystelectasis. Diagnostics, including transthoracic (TTE) and transesophageal echocardiography (TEE), revealed a severe aortic valve stenosis (&#x394;p<sub>mean</sub>&#x2009;=&#x2009;83&#xA0;mmHg, effective orifice area (EOA)&#x2009;=&#x2009;0.4&#xA0;cm<sup>2</sup>) [<xref ref-type="bibr" rid="CR6">6</xref>]. The selective coronary angiography identified a coronary sclerosis without significant stenosis. In consequence to his severe mitral valve vitium the patient received a 27&#xA0;mm bileaflet mechanical mitral valve prosthesis (Carbomedics, Sorin Group, Milano, Italy) 17&#xA0;years prior to the current symptomatic episode. Echocardiographic survey showed no signs of malfunction of the mitral valve prosthesis. Due to the medical history including chronic atrial fibrillation and mechanical mitral valve prosthesis the patient received anticoagulant therapy (vitamin K antagonists). Additional comorbidities are listed in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>. The patient was suffering from pre-renal, recently compensated chronic kidney insufficiency and had a history of duodenal ulcers, ischemic colitis, and bladder carcinoma.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Preoperative demographics</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Patient 1</th><th>Patient 2</th></tr></thead><tbody><tr><td>Age [y]</td><td>76</td><td>74</td></tr><tr><td>Sex</td><td>Male</td><td>Male</td></tr><tr><td>EOA [cm<sup>2</sup>]</td><td>0.4</td><td>0.7</td></tr><tr><td>EOAI [cm<sup>2</sup>/m<sup>2</sup>]</td><td>0.21</td><td>0.32</td></tr><tr><td>Pre-op &#x394;P<sub>mean</sub> [mmHg]</td><td>83</td><td>35</td></tr><tr><td>LVEF [%]</td><td>61</td><td>65</td></tr><tr><td>NYHA-class</td><td>III</td><td>III</td></tr><tr><td>NTproBNP [pg/ml]</td><td>1086</td><td>2461</td></tr><tr><td>CCS</td><td>I</td><td>II</td></tr><tr><td>CABG</td><td>No</td><td>Yes</td></tr><tr><td>MVR</td><td>Mechanical Valve (Carbomedics, 27&#xA0;mm)</td><td>Biological Valve (Perimount Plus, 27&#xA0;mm)</td></tr><tr><td>Chronic atrial fibrillation</td><td>Yes</td><td>Yes</td></tr><tr><td>COPD [GOLD]</td><td>IV</td><td>III</td></tr><tr><td>PHT</td><td>Moderate</td><td>Severe</td></tr><tr><td>PAD [Fontaine]</td><td>II</td><td>II</td></tr><tr><td>EuroSCORE I [%]</td><td>32.83</td><td>55.56</td></tr><tr><td>EuroSCORE II [%]</td><td>11.61</td><td>11.08</td></tr><tr><td>STS-score, PROM [%]</td><td>5.52</td><td>6.72</td></tr></tbody></table><table-wrap-foot><p>(<italic>CABG</italic> coronary artery bypass grafting, <italic>CCS</italic> Canadian Cardiovascular Society, <italic>COPD</italic> chronic obstructive pulmonary disease, <italic>EOA</italic> effective orifice area, <italic>EOAI</italic> effective orifice area index, <italic>EuroSCORE</italic> European System for Cardiac Operative Risk Evaluation, <italic>LVEF</italic> left ventricular ejection fraction, <italic>MVR</italic> Mitral valve replacement, <italic>NYHA</italic> New York Heart Association, <italic>PAD</italic> peripheral arterial disease-fontaine classification, <italic>PHT</italic> pulmonary hypertension, <italic>Pre-Op &#x394;p</italic>
<sub><italic>mean</italic></sub> preoperative mean transaortic pressure gradient, STS-score, <italic>PROM</italic> Society of Thoracic Surgeons-score, predictive risk of mortality, <italic>y</italic> years)</p></table-wrap-foot></table-wrap></p>
      <p>The second case is a 74&#xA0;year old patient complaining about progressive dyspnea (NYHA III) and episodes of stable load-dependent angina pectoris. Diagnostics also identified a severe aortic valve stenosis (TTE: &#x394;p<sub>mean</sub>&#x2009;=&#x2009;41&#xA0;mmHg; cardiac catheter: &#x394;p<sub>mean</sub>&#x2009;=&#x2009;35&#xA0;mmHg, EOA&#x2009;=&#x2009;0.7&#xA0;cm<sup>2</sup> (according to Gorlin formula)) and coronary angiography showed still open bypasses after coronary artery bypass grafting in 2011. Due to chronic atrial fibrillation the patient received therapy with vitamin K antagonists as well. In addition to the preoperative demographics (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>), the patient received a pacemaker 4 years ago, because of bradyarrhythmia and was suffering from chronic lymphatic leukemia, recently in remission. In contrast to the first case, this patient received a 27&#xA0;mm biological mitral valve prosthesis (Perimount Plus, Carpentier-Edwards, Irvine, USA) in 2011 with still excellent function.</p>
      <p>Preoperative risk evaluation of perioperative mortality using the EuroSCORE (European System for Cardiac Operative Risk Evaluation) and the STS-Score (Society of Thoracic Surgeons) showed a high perioperative risk for both patients (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Furthermore, the patients strictly denied surgical aortic valve replacement via median sternotomy.</p>
      <p>The cases were discussed by our multidisciplinary team of interventional cardiologists and cardiac surgeons as recommended [<xref ref-type="bibr" rid="CR7">7</xref>] and after considering preoperative diagnostics and all available treatment options, a transapical approach for transcatheter aortic valve implantation was favored. The annulus size of the aortic valve as well as the optimal angulation was determined preoperatively with gated CTA (Computed Tomography Angiography). The procedure was performed in general anesthesia in a fully equipped hybrid operating room as described previously [<xref ref-type="bibr" rid="CR8">8</xref>]. An anterolateral approach via the 5th intercostal space was used for exposure of the apex. Rapid pacing was applied for balloon aortic valvuloplasty with a 22&#xA0;mm balloon (NuCLEUS&#x2122;, pfm medical AG, Cologne, Germany). A self-expandable prosthesis (27&#xA0;mm JenaValve&#x2122;, JenaValve Technology GmbH, Munich, Germany) was implanted in typical manner after positioning with optimal angulation without rapid pacing or hemodynamic instability. Neither transesophageal echocardiography nor aortography identified a para- or transvalvular regurgitation in both cases (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a, b</xref>). The patients were either extubated in the operating room or shortly after being transferred to the intensive care unit for further monitoring. Patient one was discharged on the 11th postoperative day (POD), patient two on POD 14. Follow up examinations (before discharge, in the rehabilitation facility and 2.8 or 1.3&#xA0;years postoperatively, respectively) were performed and both patients presented with dyspnea according to NYHA II without echocardiographic evidence of paravalvular leakage at each point in time (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>). In the last examination, mean transaortic pressure gradient was 17 and 18&#xA0;mmHg, respectively.<fig id="Fig1"><label>Fig. 1</label><caption><p>TAVI in a patient with <bold>a</bold> mechanical mitral valve prosthesis and <bold>b</bold> biological mitral valve prosthesis</p></caption><graphic xlink:href="13019_2016_521_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>Intra- and postoperative data</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Patient 1</th><th>Patient 2</th></tr></thead><tbody><tr><td>Skin-to-skin time [min]</td><td>63</td><td>52</td></tr><tr><td>Ventilation time [h]</td><td>10</td><td>0</td></tr><tr><td>ICU-stay [d]</td><td>3</td><td>1</td></tr><tr><td>Total hospital stay [d]</td><td>11</td><td>14</td></tr><tr><td>Aortic regurgitation discharge</td><td>None</td><td>None</td></tr><tr><td>Paravalvular leakage discharge</td><td>None</td><td>None</td></tr><tr><td>&#x394;P<sub>mean</sub> [mmHg] discharge</td><td>10</td><td>14</td></tr><tr><td>NYHA-class discharge</td><td>II</td><td>II</td></tr><tr><td>Paravalvular leakage follow up</td><td>None</td><td>None</td></tr><tr><td>&#x394;P<sub>mean</sub> [mmHg] follow up</td><td>17</td><td>18</td></tr><tr><td>Mitral prosthesis dysfunction follow up</td><td>None</td><td>None</td></tr></tbody></table><table-wrap-foot><p>
<italic>d</italic> days, <italic>h</italic> hours, <italic>ICU</italic> intensive care unit, <italic>NYHA</italic> New York Heart Association, <italic>&#x394;P</italic>
<sub><italic>mean</italic></sub> mean transaortic pressure gradient</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec3">
      <title>Conclusions</title>
      <p>After a few reports about implanting JenaValve&#x2122; in patients with mechanical mitral valve prosthesis [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>], we report here a case of transcatheter aortic valve implantation using the self-expandable JenaValve&#x2122; in a patient with history of biological mitral valve prosthesis.</p>
      <p>Patients with symptomatic aortic valve stenosis that qualify for transcatheter implantation with pre-existing both, biological or mechanical mitral valve prostheses, are still a rare but increasing entity [<xref ref-type="bibr" rid="CR1">1</xref>]. On the other hand, the perioperative risk of morbidity and mortality is elevated in patients undergoing conventional aortic valve replacement with previous median sternotomy [<xref ref-type="bibr" rid="CR3">3</xref>]. Since TAVI-procedures were performed patients with pre-existing heart valve prostheses can be offered a new valid therapy option.</p>
      <p>The first case of AS treated by TAVI in a patient with previous MVR was reported by Rodes-Gabau in 2008 [<xref ref-type="bibr" rid="CR11">11</xref>]. Since then further publications reported the use of transapical [<xref ref-type="bibr" rid="CR9">9</xref>&#x2013;<xref ref-type="bibr" rid="CR15">15</xref>], transfemoral [<xref ref-type="bibr" rid="CR15">15</xref>&#x2013;<xref ref-type="bibr" rid="CR20">20</xref>] and even direct aortic [<xref ref-type="bibr" rid="CR19">19</xref>] approaches to replace a severely stenotic aortic valve following MVR with different types of mechanical and biological mitral valve prostheses [<xref ref-type="bibr" rid="CR9">9</xref>&#x2013;<xref ref-type="bibr" rid="CR21">21</xref>] or mitral valve reconstructions [<xref ref-type="bibr" rid="CR19">19</xref>]. Possible complications, the risk of embolization or interference due to the mitral prosthesis&#x2019; struts, may complicate those procedures [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Therefore, such patients were excluded from the Partner trial [<xref ref-type="bibr" rid="CR22">22</xref>] and Medtronic CoreValve U.S. Pivotal Trial [<xref ref-type="bibr" rid="CR23">23</xref>].</p>
      <p>In contrast to the right ventricle with its dedicated outflow tract the left ventricle has a common aortic-mitral orifice with a close anatomical and physiological relationship between the aortic and mitral valve. The presence of a prosthetic mitral valve reduces the aortic-mitral distance and can therefore complicate an aortic valve implantation [<xref ref-type="bibr" rid="CR24">24</xref>]. Additionally, the presence of a rigid mechanical structure instead of fibrotic tissue contributes to aggravate the situation [<xref ref-type="bibr" rid="CR12">12</xref>]. These two mechanisms are the main causes for insufficient opening of the transcatheter valves, dislocation [<xref ref-type="bibr" rid="CR13">13</xref>] or embolization [<xref ref-type="bibr" rid="CR11">11</xref>]. Thus, despite good positioning of the CoreValve&#xAE; prosthesis (Medtronic Inc., Minneapolis, USA), it can interfere with the opening of the mitral prosthesis&#x2019; leaflets and cause a life-threatening situation [<xref ref-type="bibr" rid="CR17">17</xref>]. Yet an excessively high implantation can lead to aortic regurgitation or even worse occlusion of the coronary arteries [<xref ref-type="bibr" rid="CR25">25</xref>]. Even dislocating of the Edwards Sapien&#xAE; (Edwards Lifesciences, Irvine, CA) aortic valve prosthesis into the left ventricle 2 weeks after implantation has been reported [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
      <p>In pre-existing biological mitral valve prosthesis, which have a different configuration compared to mechanical mitral valve prosthesis with more prominent commissural struts reaching into the left ventricular outflow tract (LVOT), TAVI procedure is even more challenging. Balloon displacement toward the aorta during inflation and valve malposition or embolization has been reported when implanting balloon expandable prostheses [<xref ref-type="bibr" rid="CR12">12</xref>].</p>
      <p>A minimum distance between the mitral valve prosthesis and the aortic annulus is recommended in both, self-expanding and balloon expandable TAVI to avoid a potential mitral valve dysfunction and to allow the correct expansion of the aortic valve prosthesis [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Therefore, preprocedural screening of the patients and particularly the evaluation of mitro-aortic distance should be done precisely by multislice computed tomography [<xref ref-type="bibr" rid="CR20">20</xref>]. Preoperative and intraprocedural transesophageal echocardiography, as well as fluoroscopy is also essential, to ensure a careful assessment of the patients&#x2019; anatomy and to monitor a precise device deployment.</p>
      <p>According to our experience, the JenaValve&#x2122; is more securing in this setting. Because the locators of the JenaValve&#x2122; are positioned into the nadir of the aortic valve sinus the lower margin does not reach more than 2&#xA0;mm into the LVOT below the aortic annulus and thus offering a reasonable safe distance that is needed to prevent interference with the mitral valve prosthesis during deployment [<xref ref-type="bibr" rid="CR9">9</xref>]. The possibility of recapturing and repositioning of the device during deployment is also one major advantage to ensure optimal positioning of the prosthesis. Furthermore, a shorter valve length will prevent asymmetrical deployment thus decreasing the risk of paravalvular leakage [<xref ref-type="bibr" rid="CR9">9</xref>].</p>
      <p>For choosing a transapical versus a transfemoral approach, recommendations should be followed [<xref ref-type="bibr" rid="CR27">27</xref>], yet a transapical approach was suggested to be more advantageous [<xref ref-type="bibr" rid="CR12">12</xref>] due to more efficient prosthesis maneuvers.</p>
      <p>Our report and the previous experience with JenaValve&#x2122; [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>] suggest that the JenaValve&#x2122; prosthesis may offer a potential advantage over other prostheses, due to its design, when implanted in patients with previous mitral valve replacement. However, larger series are needed to proof the anticipated superiority of the JenaValve&#x2122; device over other prosthesis.</p>
    </sec>
    <sec id="Sec4">
      <title>Abbreviations</title>
      <p>AS, aortic stenosis; AVR, aortic valve replacement; CABG, coronary artery bypass grafting; CTA, computed tomography angiography; EOA, effective orifice area; EuroSCORE, European System for Cardiac Operative Risk Evaluation; LVOT, left ventricular outflow tract; MVR, Mitral valve replacement; NYHA, New York Heart Association; POD, postoperative day; STS, Society of Thoracic Surgeons; TAVI, transcatheter aortic valve implantation</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>There are no acknowledgements.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>This study has not been funded by any research grant.</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and materials</title>
        <p>As this is a case report, there is no dataset available.</p>
      </sec>
      <sec id="FPar3">
        <title>Authors&#x2019; contributions</title>
        <p>HB and UF made substantial contribution to conception and design of the study. KW, SA, and CR were responsible for acquisition of data. HB, KW, and UF were involved in drafting the manuscript. All authors participated in revising the manuscript and provided important intellectual contributions. All authors gave final approval of the version to be published and take public responsibility for appropriate content of the manuscript. All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy of the work are appropriately investigated and resolved.</p>
      </sec>
      <sec id="FPar4">
        <title>Competing interests</title>
        <p>S. Ahad, U. Franke, and H. Baumbach are working as consultant physician for JenaValve Technology GmbH. H. Baumbach is working as consultant physician for Edwards Lifesciences.</p>
      </sec>
      <sec id="FPar5">
        <title>Consent for publication</title>
        <p>We do not report individual details and all images are entirely unidentifiable.</p>
      </sec>
      <sec id="FPar6">
        <title>Ethics approval and consent to participate</title>
        <p>An ethics approval has been requested.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vaturi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Adler</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shapira</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sahar</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vidne</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The natural history of aortic valve disease after mitral valve surgery</article-title>
          <source>J Am Coll Cardiol</source>
          <year>1999</year>
          <volume>33</volume>
          <fpage>2003</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1016/S0735-1097(99)00112-6</pub-id>
          <pub-id pub-id-type="pmid">10362206</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Unger</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lancellotti</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>de Canni&#xE9;re</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The clinical challenge of concomitant aortic and mitral valve stenosis</article-title>
          <source>Acta Cardiol</source>
          <year>2016</year>
          <volume>71</volume>
          <fpage>3</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">26853247</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>O'kane</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gladstone</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Sarsam</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Campalani</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>MacGowan</surname>
              <given-names>SW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Repeat heart valve surgery: risk factors for operative mortality</article-title>
          <source>J Thorac Cardiovasc Surg</source>
          <year>2011</year>
          <volume>122</volume>
          <fpage>913</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1067/mtc.2001.116470</pub-id>
          <pub-id pub-id-type="pmid">11689796</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Leon</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Mack</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Moses</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Svensson</surname>
              <given-names>LG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transcatheter versus surgical aortic-valve replacement in high-risk patients</article-title>
          <source>N Engl J Med</source>
          <year>2011</year>
          <volume>364</volume>
          <fpage>2187</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa1103510</pub-id>
          <pub-id pub-id-type="pmid">21639811</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Drews</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Pasic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Buz</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Unbehaun</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dreysse</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kukucka</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transapical aortic valve implantation after previous heart surgery</article-title>
          <source>Eur J Cardiothorac Surg</source>
          <year>2011</year>
          <volume>39</volume>
          <fpage>625</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejcts.2010.06.023</pub-id>
          <pub-id pub-id-type="pmid">20691604</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vahanian</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Alfieri</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Al-Attar</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Antunes</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bax</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cormier</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European association of cardio-thoracic surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)</article-title>
          <source>EuroIntervention</source>
          <year>2008</year>
          <volume>4</volume>
          <fpage>193</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.4244/EIJV4I2A36</pub-id>
          <pub-id pub-id-type="pmid">19110783</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thomas</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Trans-catheter aortic valve implantation in the United Kingdom: NICE guidance</article-title>
          <source>Heart</source>
          <year>2009</year>
          <volume>95</volume>
          <fpage>674</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1136/hrt.2008.153817</pub-id>
          <pub-id pub-id-type="pmid">18801780</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walther</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Dewey</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Borger</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kempfert</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Linke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Becht</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transapical aortic valve implantation: step by step</article-title>
          <source>Ann Thorac Surg</source>
          <year>2009</year>
          <volume>87</volume>
          <fpage>276</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="doi">10.1016/j.athoracsur.2008.08.017</pub-id>
          <pub-id pub-id-type="pmid">19101311</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O'Sullivan</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Casserly</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hurley</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Transapical JenaValve in a patient with mechanical mitral valve prosthesis</article-title>
          <source>Catheter Cardiovasc Interv</source>
          <year>2015</year>
          <volume>85</volume>
          <fpage>916</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1002/ccd.25415</pub-id>
          <pub-id pub-id-type="pmid">24478237</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mieres</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Men&#xE9;ndez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fern&#xE1;ndez-Pereira</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rubio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rodriguez</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
          <article-title>Transapical Implantation of a 2nd-Generation JenaValve Device in Patient with extremely high surgical risk</article-title>
          <source>Case Rep Cardiol</source>
          <year>2015</year>
          <volume>2015</volume>
          <fpage>458151</fpage>
          <pub-id pub-id-type="pmid">26346128</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodes-Cabau</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dumont</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mir&#xF3;</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Doyle</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>De Larochelli&#xE8;re</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Clavel</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Apical aortic valve implantation in a patient with a mechanical valve prosthesis in mitral position</article-title>
          <source>Circ Cardiovasc Interv</source>
          <year>2008</year>
          <volume>1</volume>
          <fpage>233</fpage>
          <pub-id pub-id-type="doi">10.1161/CIRCINTERVENTIONS.108.813592</pub-id>
          <pub-id pub-id-type="pmid">20031683</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Soon</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lichtenstein</surname>
              <given-names>SV</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Cheung</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Transapical transcatheter aortic valve implantation in the presence of a mitral prosthesis</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2011</year>
          <volume>58</volume>
          <fpage>715</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jacc.2011.04.023</pub-id>
          <pub-id pub-id-type="pmid">21816307</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baumbach</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hansen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Franke</surname>
              <given-names>UF</given-names>
            </name>
          </person-group>
          <article-title>Severe aortic insufficiency after transapical aortic valve implantation</article-title>
          <source>Ann Thorac Surg</source>
          <year>2011</year>
          <volume>92</volume>
          <fpage>728</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/j.athoracsur.2011.02.047</pub-id>
          <pub-id pub-id-type="pmid">21801932</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scherner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Strauch</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Haldenwang</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Baer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wahlers</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Successful transapical aortic valve replacement in a patient with a previous mechanical mitral valve replacement</article-title>
          <source>Ann Thoracic Surg</source>
          <year>2009</year>
          <volume>88</volume>
          <fpage>1662</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1016/j.athoracsur.2009.04.078</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beller</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Bekeredjian</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Krumsdorf</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Leipold</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Katus</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Karck</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transcatheter aortic valve implantation after previous mechanical mitral valve replacement: expanding indications?</article-title>
          <source>Heart Surg Forum</source>
          <year>2011</year>
          <volume>14</volume>
          <fpage>E166</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.1532/HSF98.20101148</pub-id>
          <pub-id pub-id-type="pmid">21676682</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Unzue</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fernandez-Friera</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Alegria-Barrero</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Medina-Peralta</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rodriguez-Rodrigo</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>Direct transfemoral aortic valve implantation in a patient with a mechanical mitral prosthesis</article-title>
          <source>Rev Esp Cardiol (Engl Ed)</source>
          <year>2013</year>
          <volume>66</volume>
          <fpage>666</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1016/j.recesp.2013.02.010</pub-id>
          <pub-id pub-id-type="pmid">24776340</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Testa</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gelpi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bedogni</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Transcatheter aortic valve implantation in a patient with mechanical mitral prosthesis: a lesson learned from an intraventricular clash</article-title>
          <source>Catheter Cardiovasc Interv</source>
          <year>2013</year>
          <volume>82</volume>
          <fpage>E621</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1002/ccd.25147</pub-id>
          <pub-id pub-id-type="pmid">23592397</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dumonteil</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Marcheix</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Berthoumieu</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Massabuau</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dieye</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Decramer</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transfemoral aortic valve implantation with pre-existent mechanical mitral prosthesis: evidence of feasibility</article-title>
          <source>JACC Cardiovasc Interv</source>
          <year>2009</year>
          <volume>2</volume>
          <fpage>897</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jcin.2009.05.023</pub-id>
          <pub-id pub-id-type="pmid">19778782</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bruschi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>De Marco</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Barosi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Colombo</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Botta</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Nonini</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Self-expandable transcatheter aortic valve implantation for aortic stenosis after mitral valve surgery</article-title>
          <source>Interact Cardiovasc Thorac Surg</source>
          <year>2013</year>
          <volume>17</volume>
          <fpage>90</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1093/icvts/ivt086</pub-id>
          <pub-id pub-id-type="pmid">23537849</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vavuranakis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vrachatis</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Kariori</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Moldovan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kalogeras</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lavda</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>TAVI in the case of preexisting mitral prosthesis: tips &amp; tricks and literature review</article-title>
          <source>J Invasive Cardiol</source>
          <year>2014</year>
          <volume>26</volume>
          <fpage>609</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">25364003</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gedikli</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Kutlu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Civelek</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ince</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Transcatheter implantation of a CoreValve aortic prosthesis in a patient with a ball-cage mechanical mitral valve</article-title>
          <source>J Heart Valve Dis</source>
          <year>2013</year>
          <volume>22</volume>
          <fpage>697</fpage>
          <lpage>700</lpage>
          <pub-id pub-id-type="pmid">24383383</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leon</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Mack</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Millder</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Moses</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Svensson</surname>
              <given-names>LG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery</article-title>
          <source>N Engl J Med</source>
          <year>2010</year>
          <volume>363</volume>
          <fpage>1597</fpage>
          <lpage>607</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa1008232</pub-id>
          <pub-id pub-id-type="pmid">20961243</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oh</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Little</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Abdelmoneim</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Reardon</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Kleiman</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regression of paravalvular aortic regurgitation and remodeling of self-expanding transcatheter aortic valve: An observation from the CoreValve U.S. Pivotal Trial</article-title>
          <source>JACC Cardiovasc Imaging</source>
          <year>2015</year>
          <volume>8</volume>
          <fpage>1364</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jcmg.2015.07.012</pub-id>
          <pub-id pub-id-type="pmid">26508386</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Latsios</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Toutouzas</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tousoulis</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Synetos</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Stathogiannis</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mastrokostopoulos</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>TAVI with the self-expandable 29&#xA0;mm core valve prosthesis in a patient with a metallic mitral valve</article-title>
          <source>Int J Cardiol</source>
          <year>2014</year>
          <volume>175</volume>
          <fpage>e4</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijcard.2014.04.038</pub-id>
          <pub-id pub-id-type="pmid">24841835</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laborde</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Brecker</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Roy</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jahangiri</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Complications at the time of transcatheter aortic valve implantation</article-title>
          <source>Methodist DeBakey Cardiovasc J</source>
          <year>2012</year>
          <volume>8</volume>
          <fpage>38</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.14797/mdcj-8-2-38</pub-id>
          <pub-id pub-id-type="pmid">22891127</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minol</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Veulemanns</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Zeus</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Blehm</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Transcatheter implantation of a newly designed aortic prosthesis in a patient with a mechanical mitral valve</article-title>
          <source>J Thorac Cardiovasc Surg</source>
          <year>2014</year>
          <volume>148</volume>
          <fpage>e202</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jtcvs.2014.05.094</pub-id>
          <pub-id pub-id-type="pmid">25131166</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vavuranakis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Voudris</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Vrachatis</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Thomopoulou</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Toutouzas</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Karavolias</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transcatheter aortic valve implantation, patient selection process and procedure: two centres&#x2019; experience of the intervention without general anaesthesia</article-title>
          <source>Hellenic J Cardiol</source>
          <year>2010</year>
          <volume>51</volume>
          <fpage>492</fpage>
          <lpage>500</lpage>
          <pub-id pub-id-type="pmid">21169181</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
